Concord Drugs Share Price

Concord Drugs Share Price

71.35
-0.17 (-0.24%)
BSE
22 Jul, 2026 • 03:30 PM
BSE: 538965 | Pharmaceuticals | Small Cap
Buy

Concord Drugs Annualised Returns

1 Year

▲13.39%

3 Years

▲37.86%

5 Years

▲17.91%

10 Years

▲1.05%

Concord Drugs Share Price Today


As of 22 Jul 2026, Concord Drugs share price is ₹71.4. The stock opened at ₹71.8 and had closed at ₹71.5 the previous day. During today’s trading session, Concord Drugs share price moved between ₹71.00 and ₹73.80, with an average price for the day of ₹72.40. Over the last 52 weeks, the stock has recorded a low of ₹49.00 and a high of ₹92.52. In terms of performance, Concord Drugs share price has declined by 5.9% over the past six months and has increased by 13.39% over the last year.

Concord Drugs Stock Performance

1W Return1.77%
1M Return-6.28%
6M Return-3.79%
1Y Return22.15%
3Y Return169.25%
Today's High₹73.8
Today's Low₹71
52-Week High₹92.52
52-Week Low₹49
Prev. Close₹71.52
Open₹71.75
Face Value₹10
Mkt Cap (Cr.)₹94
PE Ratio90.32

Concord Drugs Share Price Chart

Concord Drugs Company background

Founded in: 1995
Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue BioAdhesive, tablets, capsules and ophthalmic preparations and Readytofill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Readytofill Pellets ensures the highest level of process integrity and product quality.The Company started with Finished Pharmaceutical Formulations and then diversified into Readytofill Pellets, to provide customers with endtoend solution to their various pharmaceutical product needs to commercial contract drug manufacturing. It is engaged in developing New products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. It operates a state of the art, cGMP contract manufacturing FormulationFillFinish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products.

Concord Drugs Financial Highlights


For the full year FY2026–2027, revenue reached ₹78.77 crore and profit touched at ₹1.06 crore.
Read More
Concord Drugs SIP Returns Calculator
₹5,000
Over the past
Total Investment of ₹3,00,000
Monthly SIP of ₹5,000 would have become ₹4,87,031 in 5 years with a gain of ₹1,87,031 (+62.34%)
Start SIP

Concord Drugs Fundamental

Market Cap (in crs)

94.00

Face Value

10

Turnover (in lacs)

1.95

Key Metrics

Qtr Change %
45.61% Gain from 52W Low
-18.4
Dividend yield 1yr %
0

Concord Drugs Key Financials

View more
Loading chart...
Concord Drugs Quarterly Revenue
Concord Drugs Yearly Revenue
Concord Drugs Quarterly Net Profit/Loss
Concord Drugs Yearly Net Profit/Loss

Concord Drugs Result Highlights

  • Concord Drugs reported a 123.1% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 264.4%.
  • Its expenses for the quarter were up by 122.6% QoQ and 259.3% YoY.
  • The net profit increased 140.9% QoQ and increased 1225.0% YoY.
  • The earnings per share (EPS) of Concord Drugs stood at 0.47 during Q4 FY 2025-26.

Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Concord Drugs Technical Analysis

Moving Averages Analysis
71.35
Current Price
Bullish Moving Averages
4
Bearish Moving Averages
12
5 EMA
70.70
10 EMA
71.30
12 EMA
71.60
20 EMA
72.90
26 EMA
73.70
50 EMA
75.80
100 EMA
76.70
200 EMA
73.30
Delivery & Volume
Loading chart...

Delivery Volume %

Day

88.40%

Week

89.70%

Month

79.00%

Delivery & Volume

Resistance & Support

72.05
Pivot
Resistance
First Resistance
73.10
Second Resistance
74.85
Third Resistance
75.90
Support
First Support
70.30
Second support
69.25
Third Support
67.50
Relative Strength Index
42.69
Money Flow Index
55.98
MACD
-2.12
MACD Signal
-2.08
Average True Range
3.77
Average Directional Index
31.50
Rate of Change (21)
-6.28
Rate of Change (125)
-10.81

Concord Drugs Peer comparison

Compare

Concord Drugs Shareholding Pattern

Promoter
45.1%
Public
54.9%

Concord Drugs Latest News

13 JUL 2026

Concord Drugs - 538965 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

25 JUN 2026

Concord Drugs - 538965 - Closure of Trading Window

01 JUN 2026

Concord Drugs - 538965 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Concord Drugs Share Price FAQs

You can easily buy Concord Drugs shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.

The 52-week high and low of Concord Drugs share price is ₹92.52 and ₹49 as of 22/7/2026.

Please be aware that Concord Drugs stock prices are subject to continuous fluctuations due to various factors.